BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15978107)

  • 1. Obesity enhances the induction of plasminogen activator inhibitor-1 by restraint stress: a possible mechanism of stress-induced renal fibrin deposition in obese mice.
    Yamamoto K; Kojima T; Adachi T; Hayashi M; Matsushita T; Takamatsu J; Loskutoff DJ; Saito H
    J Thromb Haemost; 2005 Jul; 3(7):1495-502. PubMed ID: 15978107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.
    Samad F; Loskutoff DJ
    Mol Med; 1996 Sep; 2(5):568-82. PubMed ID: 8898373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.
    Yamamoto K; Takeshita K; Shimokawa T; Yi H; Isobe K; Loskutoff DJ; Saito H
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):890-5. PubMed ID: 11792849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
    J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging.
    Yamamoto K; Shimokawa T; Yi H; Isobe K; Kojima T; Loskutoff DJ; Saito H
    Am J Pathol; 2002 Nov; 161(5):1805-14. PubMed ID: 12414527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor gene expression in the adipose tissues of obese mice.
    Samad F; Pandey M; Loskutoff DJ
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7591-6. PubMed ID: 9636194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouse.
    Takeshita K; Yamamoto K; Ito M; Kondo T; Matsushita T; Hirai M; Kojima T; Nishimura M; Nabeshima Y; Loskutoff DJ; Saito H; Murohara T
    Semin Thromb Hemost; 2002 Dec; 28(6):545-54. PubMed ID: 12536348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis.
    Kitching AR; Kong YZ; Huang XR; Davenport P; Edgtton KL; Carmeliet P; Holdsworth SR; Tipping PG
    J Am Soc Nephrol; 2003 Jun; 14(6):1487-95. PubMed ID: 12761249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.
    Samad F; Yamamoto K; Pandey M; Loskutoff DJ
    Mol Med; 1997 Jan; 3(1):37-48. PubMed ID: 9132278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1.
    Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS
    J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice.
    Zaman AK; Fujii S; Sawa H; Goto D; Ishimori N; Watano K; Kaneko T; Furumoto T; Sugawara T; Sakuma I; Kitabatake A; Sobel BE
    Circulation; 2001 Jun; 103(25):3123-8. PubMed ID: 11425779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.
    Ito S; Iwaki S; Koike K; Yuda Y; Nagasaki A; Ohkawa R; Yatomi Y; Furumoto T; Tsutsui H; Sobel BE; Fujii S
    Coron Artery Dis; 2013 Dec; 24(8):642-50. PubMed ID: 24212262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis.
    Keeton M; Ahn C; Eguchi Y; Burlingame R; Loskutoff DJ
    Kidney Int; 1995 Jan; 47(1):148-57. PubMed ID: 7731140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis.
    Yamamoto K; Loskutoff DJ
    Am J Pathol; 1997 Sep; 151(3):725-34. PubMed ID: 9284821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial METTL3 (Methyltransferase-Like 3) Inhibits Fibrinolysis by Promoting PAI-1 (Plasminogen Activator Inhibitor-1) Expression Through Enhancing Jun Proto-Oncogene N6-Methyladenosine Modification.
    Bai Q; Lu Y; Chen Y; Zhang H; Zhang W; Wu H; Wen A
    Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):2877-2889. PubMed ID: 34645279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging and obesity augment the stress-induced expression of tissue factor gene in the mouse.
    Yamamoto K; Shimokawa T; Yi H; Isobe K; Kojima T; Loskutoff DJ; Saito H
    Blood; 2002 Dec; 100(12):4011-8. PubMed ID: 12393670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats.
    Zhang ZG; Chopp M; Goussev A; Lu D; Morris D; Tsang W; Powers C; Ho KL
    J Neurosci; 1999 Dec; 19(24):10898-907. PubMed ID: 10594071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
    Oikawa T; Freeman M; Lo W; Vaughan DE; Fogo A
    Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease.
    Lundgren CH; Brown SL; Nordt TK; Sobel BE; Fujii S
    Circulation; 1996 Jan; 93(1):106-10. PubMed ID: 8616916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure.
    Wang Y; Pratt JR; Hartley B; Evans B; Zhang L; Sacks SH
    Kidney Int; 1997 Aug; 52(2):371-7. PubMed ID: 9263992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.